DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Given Consensus Rating of “Hold” by Analysts

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have been assigned an average recommendation of “Hold” from the nine research firms that are currently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is $29.50.

XRAY has been the topic of a number of recent research reports. Needham & Company LLC cut their target price on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. Leerink Partnrs downgraded shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Evercore ISI decreased their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday. Finally, Barrington Research cut their price target on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, November 8th.

Institutional Trading of DENTSPLY SIRONA

A number of institutional investors and hedge funds have recently modified their holdings of XRAY. M&T Bank Corp raised its holdings in shares of DENTSPLY SIRONA by 5.6% during the third quarter. M&T Bank Corp now owns 39,079 shares of the medical instruments supplier’s stock valued at $1,058,000 after buying an additional 2,062 shares during the last quarter. Barclays PLC increased its position in DENTSPLY SIRONA by 21.8% in the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock valued at $8,301,000 after acquiring an additional 54,920 shares during the period. Y Intercept Hong Kong Ltd raised its stake in DENTSPLY SIRONA by 28.8% during the 3rd quarter. Y Intercept Hong Kong Ltd now owns 30,823 shares of the medical instruments supplier’s stock valued at $834,000 after acquiring an additional 6,899 shares in the last quarter. MML Investors Services LLC boosted its position in DENTSPLY SIRONA by 2.1% during the 3rd quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier’s stock worth $803,000 after acquiring an additional 620 shares during the period. Finally, iSAM Funds UK Ltd bought a new position in shares of DENTSPLY SIRONA in the third quarter worth $394,000. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Trading Down 1.9 %

Shares of XRAY opened at $18.52 on Thursday. The firm’s fifty day moving average is $23.54 and its two-hundred day moving average is $25.20. The stock has a market cap of $3.68 billion, a PE ratio of -8.95, a price-to-earnings-growth ratio of 1.81 and a beta of 1.02. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA has a 52-week low of $17.21 and a 52-week high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. The business had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business’s revenue was up .4% on a year-over-year basis. During the same period last year, the company posted $0.49 EPS. Research analysts forecast that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.